Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Two Different Schedules of Lapatinib (GW572016) in Combination With Vinorelbine in Advanced Solid Tumors

NCT00389922 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT00389922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00389922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Two Different Schedules of Lapatinib (GW572016) in Combination With Vinorelbine in Advanced Solid Tumors
Lead sponsor
University of California, Davis
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2005
Completion date
December 31, 2011
Enrollment
22 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific